These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11996813)

  • 21. Oxycellulose as mucoadhesive polymer in buccal tablets.
    Gajdziok J; Bajerová M; Chalupová Z; Rabisková M
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1115-30. PubMed ID: 20545516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties.
    Peh KK; Wong CF
    J Pharm Pharm Sci; 1999; 2(2):53-61. PubMed ID: 10952770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of formulation on the antimicrobial activity of cetylpyridinium chloride in candy based lozenges.
    Richards RM; Xing JZ; Weir LF
    Pharm Res; 1996 Apr; 13(4):583-7. PubMed ID: 8710750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and evaluation of a buccoadhesive propranolol tablet formulation.
    Celebi N; Kişlal O
    Pharmazie; 1995 Jul; 50(7):470-2. PubMed ID: 7675890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses.
    Stookey GK; Beiswanger B; Mau M; Isaacs RL; Witt JJ; Gibb R
    Am J Dent; 2005 Jul; 18 Spec No():24A-28A. PubMed ID: 16178133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers.
    Akbari J; Nokhodchi A; Farid D; Adrangui M; Siahi-Shadbad MR; Saeedi M
    Farmaco; 2004 Feb; 59(2):155-61. PubMed ID: 14871508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of bioadhesive buccal tablets for felodipine and pioglitazone in combined dosage form: in vitro, ex vivo, and in vivo characterization.
    Palem CR; Gannu R; Yamsani SK; Yamsani VV; Yamsani MR
    Drug Deliv; 2011 Jul; 18(5):344-52. PubMed ID: 21351826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and evaluation of controlled release Eudragit buccal patches.
    Wong CF; Yuen KH; Peh KK
    Int J Pharm; 1999 Feb; 178(1):11-22. PubMed ID: 10205621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro Antimicrobial Effect of Bioadhesive Oral Membrane with Chlorhexidine Gel.
    Kloster AP; Lourenço Neto N; Costa SAD; Oliveira TM; Oliveira RC; Machado MAAM
    Braz Dent J; 2018; 29(4):354-358. PubMed ID: 30462761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of Oral Streptococci to Chlorhexidine and Cetylpyridinium Chloride.
    So Yeon L; Si Young L
    Biocontrol Sci; 2019; 24(1):13-21. PubMed ID: 30880309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal effect of electrospun nanofibers containing cetylpyridinium chloride against Candida albicans.
    Santos VA; Viera PV; Oliveira AM; Zanin MH; Borsatti MA
    Braz Oral Res; 2014; 28():. PubMed ID: 25229788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy of a 0.07% cetylpyridinium chloride mouth rinse in relation to plaque and gingivitis: a 6-month randomized, vehicle-controlled clinical trial.
    Van Leeuwen MP; Rosema NA; Versteeg PA; Slot DE; Van Winkelhoff AJ; Van der Weijden GA
    Int J Dent Hyg; 2015 May; 13(2):93-103. PubMed ID: 25040299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of a preprocedural mouthrinse containing cetylpyridinium chloride in reducing bacteria in the dental office.
    Feres M; Figueiredo LC; Faveri M; Stewart B; de Vizio W
    J Am Dent Assoc; 2010 Apr; 141(4):415-22. PubMed ID: 20354090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine.
    Ikinci G; Capan Y; Senel S; Alaaddinoğlu E; Dalkara T; Hincal AA
    Pharmazie; 2000 Oct; 55(10):762-5. PubMed ID: 11082839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of toothpaste on the plaque inhibitory properties of a cetylpyridinium chloride mouth rinse.
    Sheen S; Eisenburger M; Addy M
    J Clin Periodontol; 2003 Mar; 30(3):255-60. PubMed ID: 12631184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial and antiplaque effects of a novel, alcohol-free oral rinse with cetylpyridinium chloride.
    Witt J; Ramji N; Gibb R; Dunavent J; Flood J; Barnes J
    J Contemp Dent Pract; 2005 Feb; 6(1):1-9. PubMed ID: 15719071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation.
    Patel UL; Chotai NP; Nagda CD
    Pharm Dev Technol; 2012; 17(1):15-22. PubMed ID: 20649410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and microbiological effects of the use of a cetylpyridinium chloride dentifrice and mouth rinse in orthodontic patients: a 3-month randomized clinical trial.
    Herrera D; Escudero N; Pérez L; Otheo M; Cañete-Sánchez E; Pérez T; Alonso B; Serrano J; Palma JC; Sanz M; Martín C
    Eur J Orthod; 2018 Sep; 40(5):465-474. PubMed ID: 29293905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial activities and release kinetics of a newly developed recoverable controlled agent-release system.
    Ehara A; Torii M; Imazato S; Ebisu S
    J Dent Res; 2000 Mar; 79(3):824-8. PubMed ID: 10765955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of cetylpyridinium chloride buccal tablets on halitosis induced by oral conditions].
    Zhang D; Liu CH; Zhang J; Cai D; Yang X; Li S; Zhong H
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1386-9. PubMed ID: 25263382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.